As part of its planning for a new senior executive operating model, the Thomas Jefferson University Board of Trustees has appointed Mark L. Tykocinski, MD, as the next President of Thomas Jefferson University, effective July 1, 2022.

New research in mice from Thomas Jefferson University has paved the way for a Phase I clinical trial and has the potential to transform vaccines against HIV and malaria.

The normal role of a gene involved in familial Alzheimer’s, neuronal clean-up crews, and how the gut microbiome might affect osteoarthritis

Cancer screening guidelines published last year expand eligibility for those at high risk for lung cancer, and new research shows that they also improve representation among African American patients.

A novel fibrotic disease with surprising nerve symptoms, an explanation for COVID immunity in the immunocompromised and a new approach for brain cancer

New research pinpoints the age of historic pieces in Jefferson’s textiles collection.

New research finds that the novel coronavirus can make the mouse brain more susceptible to a toxin that induces nerve-cell loss seen in Parkinson’s. 

The innovative and inspirational clinical trial called Cortimo, led by Thomas Jefferson University and Jefferson Health, was honored in the World Changing Ideas’ health category of Fast Company’s 2022 World Changing Ideas Awards.

How steroids affect cancer immunotherapy, the powerhouse of neurodegeneration and the molecules behind learning and memory

Understanding how some of the world’s richest people hide their wealth in order to avoid taxation and accountability.